TITLE:
Role of Chemohormonal Therapy in Management of Patients with Metastatic Hormone Sensitive Prostate Cancer
AUTHORS:
Sanjay Hinduja, Adnan Khan, Uzair B. Chaudhary
KEYWORDS:
Metastatic Prostate Cancer, Hormone Sensitive Disease
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.8 No.13,
December
13,
2017
ABSTRACT: Androgen deprivation therapy has been the mainstay of treatment for management
of metastatic hormone sensitive prostate cancer. Recently conducted randomized
controlled trials with docetaxel based chemotherapy have shed light on benefit
of early use chemotherapy for hormone sensitive prostate cancer. In this review,
we aim to comprehensively describe recent trials which are changing the
paradigm in support of up front use of docetaxel based chemotherapy for
metastatic hormone sensitive prostate cancer.